Stroke
Articles 17-32 of 242
- Medical NewsFDA Grants Breakthrough Therapy Designation to Sublingual Treatment for Acute Ischemic Stroke
Sanbexin (edaravone and dexborneol; Simcere, Nanjing, China) sublingual tablets have been granted Breakthrough Therapy designation by the Food and Drug Administration (FDA) for the treatment of acute ischemic stroke (AIS). The designation was granted based on positive data from the TASTE-SL phase 3 ...
09/10/2024